A5114377345- Rheumatoid Arthritis Research and Therapies
- Autoimmune and Inflammatory Disorders Research
- Biosimilars and Bioanalytical Methods
- Clinical Reasoning and Diagnostic Skills
- Health Systems, Economic Evaluations, Quality of Life
- Systemic Lupus Erythematosus Research
- HER2/EGFR in Cancer Research
- Medical Imaging Techniques and Applications
- Organ Transplantation Techniques and Outcomes
- Radiomics and Machine Learning in Medical Imaging
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Advanced MRI Techniques and Applications
- Spondyloarthritis Studies and Treatments
- Chronic Lymphocytic Leukemia Research
Université de Lorraine
2014-2020
Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est
2018-2020
Université de Caen Normandie
2020
Centre Hospitalier Universitaire de Caen Normandie
2020
Sorbonne Université
2018
Université Paris Cité
2016-2018
Sorbonne Paris Cité
2018
Pitié-Salpêtrière Hospital
2018
Assistance Publique – Hôpitaux de Paris
2018
Centre Hospitalier Régional et Universitaire de Nancy
2016
Objective To determine whether patient global assessment of disease activity (PtGA) over the first year course, as part a Boolean‐based definition remission and considered individually, had significant relationship with structural progression 3 years in patients early arthritis. Methods We conducted prospective, observational study using ESPOIR (Étude et Suivi des Polyarthrites Indifférenciées Récentes) cohort data. Remission states were defined 1) 4‐variable remission, which included tender...
<h3>Background</h3> The recently developed ACR/EULAR Boolean remission criteria for rheumatoid arthritis (RA) include not only joint accounts and CRP, but also patient global assessment (assessed by a visual analog scale, VAS) with threshold value of 1/10 (ref). However, often seems to be limiting factor achieving remission. <h3>Objectives</h3> To explore the role VAS in remission: according disease duration, formulation used VAS. <h3>Methods</h3> <i>Patients</i>: those ESPOIR COMEDRA...